Assignee
MEDIMMUNE LTD
GB·171 granted patents·155 pending applications·1,250 citations·filing 2003–2025
Top patents by PatentIndex Score
326 records- 0197US10646584B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2019·Granted May 12, 2020·8 cites·8 claims
- 0297US7521051B2Methods of upmodulating adaptive immune response using anti-PD-1 antibodiesMEDIMMUNE LTD·Filed 2003·Granted Apr 21, 2009·376 cites·15 claims
- 0396US12121590B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2023·Granted Oct 22, 2024·1 cites·16 claims
- 0496US9376440B2Pyrrolobenzodiazepines as antiproliferative agentsMEDIMMUNE LTD·Filed 2013·Granted Jun 28, 2016·37 cites·20 claims
- 0595US10035843B2RSV-specific binding moleculeMEDIMMUNE LTD·Filed 2016·Granted Jul 31, 2018·10 cites·20 claims
- 0695US9624227B2Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseasesMEDIMMUNE LTD·Filed 2014·Granted Apr 18, 2017·26 cites·17 claims
- 0795US9493565B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2014·Granted Nov 15, 2016·50 cites·8 claims
- 0895US9415117B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2013·Granted Aug 16, 2016·31 cites·19 claims
- 0995US8877189B2Binding members for interleukin-4 receptor alpha (IL-4Rα) - 173MEDIMMUNE LTD·Filed 2013·Granted Nov 4, 2014·49 cites·15 claims
- 1095US7973140B2Antibodies directed to angiopoietin-2 and uses thereofMEDIMMUNE LTD·Filed 2005·Granted Jul 5, 2011·36 cites·11 claims
- 1194US9938356B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2015·Granted Apr 10, 2018·26 cites·9 claims
- 1294US9670521B2Amino acid derivativesMEDIMMUNE LTD·Filed 2013·Granted Jun 6, 2017·22 cites·13 claims
- 1394US9562049B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2013·Granted Feb 7, 2017·29 cites·23 claims
- 1494US9399641B2Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugatesMEDIMMUNE LTD·Filed 2012·Granted Jul 26, 2016·28 cites·76 claims
- 1594US9388187B2PyrrolobenzodiazepinesMEDIMMUNE LTD·Filed 2012·Granted Jul 12, 2016·28 cites·14 claims
- 1693US12173050B2RSV-specific antibodies and functional parts thereofMEDIMMUNE LTD·Filed 2023·Granted Dec 24, 2024·1 cites·21 claims
- 1793US11286294B2Anti-RSV monoclonal antibody formulationMEDIMMUNE LTD·Filed 2021·Granted Mar 29, 2022·3 cites·30 claims
- 1893US10662239B2Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2017·Granted May 26, 2020·9 cites·12 claims
- 1993US10010624B2Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2014·Granted Jul 3, 2018·9 cites·11 claims
- 2093US9283274B2RSV specific binding moleculeMEDIMMUNE LTD·Filed 2013·Granted Mar 15, 2016·9 cites·34 claims
- 2192US11286297B2Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2020·Granted Mar 29, 2022·4 cites·17 claims
- 2292US9956298B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2014·Granted May 1, 2018·24 cites·14 claims
- 2392US9732084B2Pyrrolobenzodiazepines used to treat proliferative diseasesMEDIMMUNE LTD·Filed 2013·Granted Aug 15, 2017·19 cites·19 claims
- 2492US9649390B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2014·Granted May 16, 2017·19 cites·13 claims
- 2592US9399073B2PyrrolobenzodiazepinesMEDIMMUNE LTD·Filed 2012·Granted Jul 26, 2016·24 cites·17 claims
- 2691US10287362B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2018·Granted May 14, 2019·10 cites·15 claims
- 2791US10059757B2RSV-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2016·Granted Aug 28, 2018·8 cites·32 claims
- 2891US9950078B2Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2014·Granted Apr 24, 2018·7 cites·11 claims
- 2991US9321774B2PyrrolobenzodiazepinesMEDIMMUNE LTD·Filed 2013·Granted Apr 26, 2016·28 cites·20 claims
- 3090US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 3190US10774133B2Anti-RSV monoclonal antibody formulationMEDIMMUNE LTD·Filed 2018·Granted Sep 15, 2020·7 cites·42 claims
- 3290US10736903B2Pyrrolobenzodiazepine-anti-PSMA antibody conjugatesMEDIMMUNE LTD·Filed 2013·Granted Aug 11, 2020·5 cites·6 claims
- 3390US10730931B2RSV-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2018·Granted Aug 4, 2020·3 cites·34 claims
- 3490US10400039B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2016·Granted Sep 3, 2019·8 cites·8 claims
- 3590US9834598B2Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2013·Granted Dec 5, 2017·9 cites·7 claims
- 3690US8858942B2Antibodies directed to ERBB2MEDIMMUNE LTD·Filed 2012·Granted Oct 14, 2014·11 cites·12 claims
- 3789US11446292B2Compounds and conjugates thereofMEDIMMUNE LTD·Filed 2021·Granted Sep 20, 2022·2 cites·15 claims
- 3889US10954308B2Antibodies to ticagrelor and methods of useMEDIMMUNE LTD·Filed 2018·Granted Mar 23, 2021·4 cites·30 claims
- 3989US10844114B2Anti-Pseudomonas Psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2019·Granted Nov 24, 2020·3 cites·21 claims
- 4089US10723786B2RSV-specific binding moleculeMEDIMMUNE LTD·Filed 2018·Granted Jul 28, 2020·3 cites·19 claims
- 4189US9284589B2Methods of obtaining a specific binding member that binds eotaxinMEDIMMUNE LTD·Filed 2014·Granted Mar 15, 2016·9 cites·12 claims
- 4289US8350011B2Antibodies to ErbB2MEDIMMUNE LTD·Filed 2007·Granted Jan 8, 2013·10 cites·7 claims
- 4388US9321831B2RSV-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2013·Granted Apr 26, 2016·8 cites·23 claims
- 4488US7947273B2Human antibody molecules for IL-13MEDIMMUNE LTD·Filed 2007·Granted May 24, 2011·10 cites·18 claims
- 4588US2025179153A1Rsv-specific antibodies and functional parts thereofMEDIMMUNE LTD·Filed 2024·Application pending·0 cites
- 4687US12344664B2Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2024·Granted Jul 1, 2025·0 cites·20 claims
- 4787US10751346B2Pyrrolobenzodiazepine—anti-PSMA antibody conjugatesMEDIMMUNE LTD·Filed 2013·Granted Aug 25, 2020·4 cites·10 claims
- 4887US10695433B2Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2013·Granted Jun 30, 2020·4 cites·8 claims
- 4987US10370436B2Anti-pseudomonas Psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2016·Granted Aug 6, 2019·5 cites·5 claims
- 5087US10335497B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2017·Granted Jul 2, 2019·3 cites·6 claims
Showing the top 50 of 326 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MEDIMMUNE LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →